1h Free Analyst Time
The cardiovascular therapeutics market is forecasted to grow by USD 24.25 mn during 2023-2028, accelerating at a CAGR of 4.57% during the forecast period. The report on the cardiovascular therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing risk factors for cardiovascular diseases, the availability of advanced diagnostic methods, and the rising prevalence of hypercholesterolemia.
The cardiovascular therapeutics market is segmented as below:
By Distribution Channel
- Hospital pharmacy
- Retail Pharmacy
- Online pharmacy
By Type
- Antithrombotic drugs
- Hypolipidemic drugs
- Others
By Geographical Landscape
- Asia
- North America
- Europe
- Rest of World (ROW)
The report on the cardiovascular therapeutics market covers the following areas:
- Cardiovascular therapeutics market sizing
- Cardiovascular therapeutics market forecast
- Cardiovascular therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global cardiovascular therapeutics market: Abbott Laboratories, Acutus Medical Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Viatris Inc., Aurobindo Pharma Ltd., and Dr Reddys Laboratories Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the advent of novel oral anticoagulants (NOACS)."
According to the report, one of the major drivers for this market is the increasing risk factors for cardiovascular diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Acutus Medical Inc.
- Amgen Inc.
- Astellas Pharma Inc.
- AstraZeneca PLC
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Co.
- Daiichi Sankyo Co. Ltd.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Johnson and Johnson Services Inc.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Viatris Inc.
- Aurobindo Pharma Ltd.
- Dr Reddys Laboratories Ltd.